Results 61 to 70 of about 14,538 (208)
Alimentary Pharmacology &Therapeutics, EarlyView.Features of clinically significant portal hypertension (CSPH) in patients with autoimmune hepatitis indicate a substantial risk for decompensation and impaired transplant‐free survival. Non‐invasive risk prediction based on liver stiffness measurement ≥ 15 kPa and/or thrombocytopenia (< 150 G/L) serves as a valuable surrogate to identify patients at ...
Lukas Burghart +10 more
wiley +1 more source
The Arab Journal of Interventional RadiologyObjective The aim of this study was to evaluate overdilation of 10-mm standard and 8–10 mm controlled-expansion Viatorr stents to 12 mm during transjugular intrahepatic portosystemic shunt (TIPS) placement when insufficient reduction (
Muhammad Mohid Tahir +6 more
doaj +1 more source
Annals of Vascular Surgery - Brief Reports and Innovations, 2022 Transjugular intrahepatic portosystemic shunt (TIPS) was routinely used via the right internal jugular vein to establish a shunt pathway from the portal vein to the hepatic vein for treatment of complications of portal hypertension.
Hongcheng Ren +8 more
doaj +1 more source
Alimentary Pharmacology &Therapeutics, EarlyView.This study shows that both the total SPSS area and the cumulative SPSS diameter decrease significantly and persistently after TIPS placement, whereas the total shunt diameter increases slightly and the total shunt area remains stable. The relative change in SPSS area serves as an independent predictor of mortality. ABSTRACT We evaluated the dynamics of
Marlene Hintersteininger +14 more
wiley +1 more source
Alimentary Pharmacology &Therapeutics, EarlyView.In‐depth multiomics analyses revealed that the gut microbiota in patients with CPH is dysbiotic. Altered gut microbiota plays an important role in the progression of CPH and affects the host's arginine metabolism to promote arginine biosynthesis. The pro‐inflammatory effects of certain gut bacteria induce iNOS expression, which together act on the ...
Qun Zhang +15 more
wiley +1 more source
Massive avascular malformations causing life threatening portal hypertension
Annals of Hepatology, 2012 We present an unusual case of extensive avascular malformations (AVMs) causing non-cirrhotic portal hypertension. This phenomenon, though previously described, is a rare clinical entity which, in the setting of life threatening portal hypertension, may ...
Aman Arya +3 more
doaj +1 more source
Ammonia : this is not the end but rather the end of the beginning [PDF]
, 2018 Hepatic encephalopathy (HE) represents a wide spectrum of neurological or neuropsychological symptoms caused by liver disease and/or portosystemic shunts.
Dam, Gitte +2 more
core +1 more source
Alimentary Pharmacology &Therapeutics, EarlyView.Extracellular matrix (ECM) remodelling biomarkers reflect portal hypertension and disease severity in advanced chronic liver disease (ACLD). However, their predictive value for disease progression is largely restricted to compensated ACLD (cACLD). ABSTRACT Background Extracellular matrix (ECM) remodelling in advanced chronic liver disease (ACLD) is ...
Benedikt Simbrunner +17 more
wiley +1 more source
The Arab Journal of Interventional RadiologyPurpose The aim of this study was to evaluate the safety and efficacy of using a trans-splenic approach for transjugular intrahepatic portosystemic shunt (TIPS) creation in patients with portal vein thrombosis. (PVT).
Maryam Boumezrag +2 more
doaj +1 more source
Alimentary Pharmacology &Therapeutics, EarlyView.Indocyanine green clearance by pulse dye densitometry correlates with portal hypertension, systemic inflammation and circulatory dysfunction in advanced chronic liver disease. While diagnostic accuracy for CSPH was limited, ICG‐R15 independently predicted decompensation and ACLF/liver‐related mortality, highlighting its prognostic value across disease ...
Mathias Jachs +17 more
wiley +1 more source